Maxine L Stitzer

Biographic Data

ID5381073
NAMEMaxine L Stitzer
GIVEN NAMESMaxine L
FAMILY NAMEStitzer
SIGNATURESTITZER M L
AFFILIATIONSJohns Hopkins University
ORCID0000-0002-1767-9561
VERIFIEDYes
TOTAL WORKS10
TOTAL CITATIONS6
AUTHOR COUNT10
EDITOR COUNT0
FIRST PUBLICATION YEAR1993
LATEST PUBLICATION YEAR2025
H-INDEX2

  • Digitally delivered contingency management during methadone treatment for people with co-occurring cocaine and opioid use: A protocol for a randomized controlled trial

    Open AccessKaren A Alexander, Karen Alexander et al.ARTICLEFrontiers in Psychiatry2025

    This project will inform the ancillary content of methadone maintenance treatment for the many patients with substance use disorders that extend beyond opioids, specifically for those who use cocaine. The study's design will provide scientifically valid information about the effectiveness of digitally delivered CM, while app usage data and qualitative data from participants will be a rich resource for interpreting outcome results. CM is the only …

  • A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users

    Open AccessM Drummond, Michael B Drummond et al.ARTICLEBMC Public Health2014

    Clinicaltrials.gov NCT01334736 (April 12, 2011)

  • The Impact of Quitting Smoking on Weight Among Women Prisoners Participating in a Smoking Cessation Intervention

    Karen L Cropsey, Leslie A McClure et al.ARTICLEAmerican Journal of Public Health2010References: 30

    Objectives. We examined the impact of smoking cessation on weight change in a population of women prisoners. Methods. Women prisoners (n = 360) enrolled in a smoking cessation intervention; 250 received a 10-week group intervention plus transdermal nicotine replacement. Results. Women who quit smoking had significant weight gain at 3- and 6-month follow-ups, with a net difference of 10 pounds between smokers and abstainers at 6 months. By the 12-…

  • Smoking Cessation Intervention for Female Prisoners: Addressing an Urgent Public Health Need

    Karen Cropsey, Karen L Cropsey et al.ARTICLEAmerican Journal of Public Health2008Cited by: 2References: 31

    Objectives. We tested the efficacy of a combined pharmacologic and behavioral smoking cessation intervention among women in a state prison in the southern United States. Methods. The study design was a randomized controlled trial with a 6-month waitlist control group. The intervention was a 10-week group intervention combined with nicotine replacement therapy. Two hundred and fifty participants received the intervention, and 289 were in the contr…

  • The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline: Findings and implications for psychologists

    David W Wetter, Michael C Fiore et al.ARTICLEAmerican Psychologist1998

    Smoking is the leading cause of preventable morbidity and mortality in the United States, and the health benefits of quitting smoking are substantial. Nevertheless, over 25% of American adults (48 million individuals) continue to smoke, and the vast majority of quit attempts are unsuccessful. The Agency for Health Care Policy and Research recently addressed the smoking problem by conducting a 2-year research project that was published as the Smok…

  • Panel and open discussions

    John M Pinney, Jack E Henningfield et al.ARTICLETobacco Control1995

    I find myself wondering whether the con ference has met our goals, and I find that it has -not because we have conclusions or a clear policy from it, however. Someone asked me what I thought was going to happen in the next year as a result of this conference, and my quick answer was, "Nothing". In fact, I think we have accomplished our goals because we have raised the right questions. You have all seen the bumper sticker that says "Question autho…

  • Policy initiatives to enhance smoking cessation and harm reduction

    Maxine L StitzerARTICLETobacco Control1995

    My research has examined both pharmacological and behavioural treat ment of drug abuse, and specifically their combination for the treatment of tobacco dependence. I am

  • Panel discussion

    Maxine L Stitzer, Michael C Fiore et al.ARTICLETobacco Control1995

    Effective clinical treatment of tobacco ad diction is a necessary component of our overall national tobacco policy. While frequently

  • Effects of a restricted work-site smoking policy on employees who smoke

    Janet Brigham, John Gross et al.ARTICLEAmerican Journal of Public Health1994Cited by: 4References: 12

    OBJECTIVES. This study evaluated the biological and subjective consequences observed in individual smokers after implementation of a workplace smoking-restriction policy. METHODS. Employees were evaluated for 4 weeks before and 4 weeks after their workplace became smoke-free (n = 34). A comparison group of smokers whose work-site smoking was unrestricted served as controls (n = 33). Daily exposure to tobacco constituents and withdrawal effects we…

  • Treatment issues: Towards a stepped-care model

    Tracy Finally, Maxine L Stitzer et al.ARTICLETobacco Control1993

    Dr Abrams is a nationally recognised researcher in addictive behaviours and chronic disease prevention who has contributed much to our understanding of substance abuse treatment, both empirically and conceptually.I'm particularly pleased that he will be making the presentation this morning that will set the stage for our discussion of the behavioural therapy components of smoking cessation treatment